Neurovascular Thrombectomy Devices Market Expected to Rise by a CAGR of 6.15% by 2028, Estimates DelveInsight | Boston Scientific Corporation, Medtronic, Acandis GmbH, Perflow Medical, Phenox GmbH and Many Others

(Albany, USA) DelveInsight's "Neurovascular Thrombectomy Devices Market and Competitive Insight Report" provides the current and forecast market and comprises Neurovascular Thrombectomy Devices market trends and key competitors. DelveInsight estimated the market to rise at a high CAGR over the study period of 2020 - 2028.

To know more about the report, request for sample report @ https://www.delveinsight.com/report-store/neurovascular-thrombectomy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Neurovascular Thrombectomy Devices Epidemiology
• The total eligible patient population for Neurovascular Thrombectomy Devices in 7MM was 30,179 cases in 2018. The largest patient pool for neurovascular thrombectomy devices was found in the United States.
• According to the CDC 2021 report, every year, more than 795,000 people in the United States have a stroke and about 610,000 of these are first or new strokes. In addition, the report also stated that 87% of all strokes are ischemic strokes, in which blood flow to the brain is blocked.
• The people taken into consideration are 45-80 years of age to calculate the eligible patient population for neurovascular thrombectomy devices. The incidence of stroke is higher in the older age population than in the younger generation.

Key Highlights of Neurovascular Thrombectomy Devices Market report:
• Mechanical Thrombectomy is one of the treatment procedure needed to treat ischemic stroke patients using neurovascular thrombectomy devices such as aspiration catheters or stent retrieval, or a combination of both.
• The COVID-19 impacted the neurovascular thrombectomy devices heavily in 2020. The market saw a steep decline from 2019 to 2020. Due to nationwide lockdowns in every country, market access was at a high-time low. Still, the market is expected to recover to its previous size by 2026.
• Fogarty® arterial embolectomy catheter (Edward LifeSciences Corporation), the Penumbra System® (Penumbra), and PRIORITYONE® Aspiration Catheter (Terumo) are some of the neurovascular thrombectomy devices in the market. Most of these available devices are FDA approved and are CE marked.
• The FDA approved Edwards Lifesciences's Fogarty Arterial Embolectomy Catheter on June 12, 2020. This will help Edwards Lifesciences expand its product portfolio, making it the most significant player in the market.
• On February 7, 2020, Stryker received FDA approval for the Trevo NXT ProVue Retriever, expanding its portfolio in Neurovascular Thrombectomy Devices.

Request for Sample Pages @ Neurovascular Thrombectomy Devices Competitive Landscape Report - https://www.delveinsight.com/report-store/neurovascular-thrombectomy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Neurovascular Thrombectomy Devices Market
The treatment algorithm for this calculated patient pool, as mentioned in the 2019 updated Guidelines from the American Heart Association/American Stroke Association, states that anticoagulant such as intravenous (IV) tissue plasminogen activator (tPA) should be administered to all eligible acute stroke patients within 3 hours of a stroke. As with IV tPA, treatment with mechanical thrombectomy should be initiated as quickly as possible. Administration of aspirin is recommended in acute stroke patients within 24 to 48 hours after stroke onset. For patients treated with IV tPA, aspirin administration is generally delayed for 24 hours.
The Neurovascular Thrombectomy Devices market growth is estimated to increase due to the growing geriatric population, increased incidence and prevalence of neurovascular diseases, advancements in healthcare technology, high healthcare expenditure, and available reimbursement policies in developed countries. Along with this, technological advancements and demand for minimum invasive surgeries are the factors responsible for the Neurovascular Thrombectomy Devices market size at a high CAGR during the forecast period.

Key Competitors in Neurovascular Thrombectomy Devices Market:
Some of the Neurovascular Thrombectomy Devices companies working in the market are Stryker, Penumbra, Inc., Vesalio, LLC., Acandis GmbH, Rapid Medical, Johnson & Johnson, Teleflex Incorporated, Medtronic, NeuroVasc Technologies, Inc., Perflow Medical, Edward LifeSciences Corporation, Terumo Europe NV, Koninklijke Philips N.V., MicroVention Inc., phenox GmbH, BIOMEDICAL SOLUTIONS INC., Ceretrieve Ltd., Anaconda Biomed SL, Genesis Medtech., and others.

Know more about the key companies involved @ Neurovascular Thrombectomy Devices Market Key Companies - https://www.delveinsight.com/report-store/neurovascular-thrombectomy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

DelveInsight's analysts have prepared this report after a thorough secondary and primary research into the Neurovascular Thrombectomy Devices market. Analysis and estimations are done by considering the share of top companies and industry expert viewpoints of Neurovascular Thrombectomy Devices and eligible patient pool for Neurovascular Thrombectomy Devices.

Table of Contents
1 Neurovascular Thrombectomy Devices Background and Overview
2 Neurovascular Thrombectomy Devices Company Profiles
3 Neurovascular Thrombectomy Devices Competitive Analysis
4 Neurovascular Thrombectomy Devices Eligible Patient Pool Analysis (2019-2027)
5 Neurovascular Thrombectomy Devices Market Analysis in the 7MM (2019-2027)
5.1 Total Neurovascular Thrombectomy Devices Market Size
5.2 Neurovascular Thrombectomy Devices Market Share by DevicesType
6 Neurovascular Thrombectomy Devices Case Study: Devices Type
7 Neurovascular Thrombectomy Devices Market Drivers and Barriers
8 Neurovascular Thrombectomy Devices: PEST Analysis

Trending Reports:
• Acral Lentiginous Melanoma Market: https://www.delveinsight.com/report-store/acral-lentiginous-melanoma-market
• Acute Pharyngitis Market: https://www.delveinsight.com/report-store/acute-pharyngitis-market
• Alopecia Market: https://www.delveinsight.com/report-store/alopecia-market
• Alzheimer Disease Market: https://www.delveinsight.com/report-store/alzheimers-disease-ad-market
• Angioedema Market: https://www.delveinsight.com/report-store/angioedema-market
• Anterior Cruciate Ligament Injuries Market: https://www.delveinsight.com/report-store/anterior-cruciate-ligament-injuries-market
• Aortic Stenosis Market: https://www.delveinsight.com/report-store/aortic-stenosis-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Automated External Defibrillators Market: https://www.delveinsight.com/report-store/automated-external-defibrillator-aed-market
• Autosomal Recessive Congenital Ichthyosis Market Size:
• Bone Anchored Hearing Systems Market: https://www.delveinsight.com/report-store/bone-anchored-hearing-systems-market
• Bronchial Spasms Market: https://www.delveinsight.com/report-store/bronchial-spasm-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Cerebral Aneurysm Market: https://www.delveinsight.com/report-store/cerebral-aneurysm-market
• Chemotherapy Induced Thrombocytopenia Market: https://www.delveinsight.com/report-store/chemotherapy-induced-thrombocytopenia-cit-market
• Cluster Headaches Market: https://www.delveinsight.com/report-store/cluster-headache-market
• Concussions Market Size: https://www.delveinsight.com/report-store/concussions-market
• Eczema Market: https://www.delveinsight.com/report-store/eczema-market
• Fibrocystic Breast Condition Market: https://www.delveinsight.com/report-store/fibrocystic-breast-condition-market
• Foot And Ankle Devices Market: https://www.delveinsight.com/report-store/foot-and-ankle-devices-market
• France Healthcare Outlook Report: https://www.delveinsight.com/report-store/france-healthcare-outlook-report
• Global Electrophysiology Devices Market: https://www.delveinsight.com/report-store/electrophysiology-devices-market
• Hpv-induced Cancers Market: https://www.delveinsight.com/report-store/hpv-induced-cancers-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Lymphocytopenia Market: https://www.delveinsight.com/report-store/lymphocytopenia-market
• Malt Lymphoma Market: https://www.delveinsight.com/report-store/malt-lymphoma-market
• Meningioma Market: https://www.delveinsight.com/report-store/meningioma-market
• Minimal Residual Disease Market: https://www.delveinsight.com/infographics/minimal-residual-disease-market
• Neurostimulation Devices Market: https://www.delveinsight.com/report-store/neurostimulation-devices-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Parkinson's Disease Market: https://www.delveinsight.com/report-store/parkinsons-disease-market-size-analysis-treatment
• Polycythemia Market: https://www.delveinsight.com/report-store/polycythemia-market
• Prefilled Syringes Market: https://www.delveinsight.com/report-store/prefilled-syringes-market
• Pressure Ulcers Market Size: https://www.delveinsight.com/report-store/negative-pressure-wound-therapy-systems-market
• Pruritus Market: https://www.delveinsight.com/report-store/pruritus-market
• Rhino Conjunctivitis Market: https://www.delveinsight.com/report-store/rhino-conjunctivitis-market
• Scleroderma Market: https://www.delveinsight.com/report-store/scleroderma-market
• Upper Limb Hypertonia Market: https://www.delveinsight.com/report-store/upper-limb-hypertonia-market

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.